A radiomics-based nomogram for differentiating minimally invasive adenocarcinoma from stage I invasive non-mucinous adenocarcinoma (CTR < 0.5, GGO-dominant).
Medicine
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.